Scholarlink

Purpose <p>First Nations people in Australia, New Zealand, Canada and the United States of America (USA) experience high rates of mental and substance-use disorders (MSDs) and face socially determined health inequalities, but this is not always well quantified. This systematic review sought to summarise best-estimates of MSD prevalence and describe related sociodemographic correlates among First Nations adults in these countries.</p> Methods <p>Relevant studies published between 1980 and 2026 were searched using PubMed, Embase, and PsycINFO following PRISMA guidelines. Epidemiological population surveys producing prevalence estimates and/or sociodemographic correlates of MSDs for representative populations of First Nations peoples were identified. Prevalence data and sociodemographic correlates were extracted and described. Meta-analyses were conducted for MSDs with at least three available estimates.</p> Results <p>A total of 50 studies from 24 unique population-level representative surveys met inclusion criteria. Surveys from the USA provided the most data (35 studies). Generally, MSD prevalence was lowest in the USA and highest in Australia, with twelve-month rates ranging between 20.9% (18.8–23.1%) and 51.7% (47.3–55.9%) respectively. Mood disorders and anxiety disorders were most prevalent. Sociodemographic variables including sex, socioeconomic factors, and regionality were associated with higher risk of certain MSDs.</p> Conclusion <p>The prevalence and related sociodemographic correlates of MSDs identified across countries are varied and have implications for risk profiles and treatment needs. Low numbers of studies and heterogeneous data-collection methodologies highlight the need for better quality, representative population level data on MSDs for First Nations peoples.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A systematic review of the prevalence and correlates of mental and substance use disorders in first nations peoples in Australia, New Zealand, Canada and the United States of America

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月29日

查看全文
  • Tabinda A. Basit,
  • Damian F. Santomauro,
  • Meredith G. Harris,
  • Harvey A. Whiteford,
  • Maree R. Toombs,
  • Megavartini Sivakumar,
  • Alize J. Ferrari

摘要

Purpose

First Nations people in Australia, New Zealand, Canada and the United States of America (USA) experience high rates of mental and substance-use disorders (MSDs) and face socially determined health inequalities, but this is not always well quantified. This systematic review sought to summarise best-estimates of MSD prevalence and describe related sociodemographic correlates among First Nations adults in these countries.

Methods

Relevant studies published between 1980 and 2026 were searched using PubMed, Embase, and PsycINFO following PRISMA guidelines. Epidemiological population surveys producing prevalence estimates and/or sociodemographic correlates of MSDs for representative populations of First Nations peoples were identified. Prevalence data and sociodemographic correlates were extracted and described. Meta-analyses were conducted for MSDs with at least three available estimates.

Results

A total of 50 studies from 24 unique population-level representative surveys met inclusion criteria. Surveys from the USA provided the most data (35 studies). Generally, MSD prevalence was lowest in the USA and highest in Australia, with twelve-month rates ranging between 20.9% (18.8–23.1%) and 51.7% (47.3–55.9%) respectively. Mood disorders and anxiety disorders were most prevalent. Sociodemographic variables including sex, socioeconomic factors, and regionality were associated with higher risk of certain MSDs.

Conclusion

The prevalence and related sociodemographic correlates of MSDs identified across countries are varied and have implications for risk profiles and treatment needs. Low numbers of studies and heterogeneous data-collection methodologies highlight the need for better quality, representative population level data on MSDs for First Nations peoples.